×
0 0 0 0.00465116279069774 -0.0041860465116279 0.0111627906976745 0.012093023255814 -0.0693023255813953
Stockreport

FDA accepts Voyager Therapeutics' IND for VY-AADC for advanced Parkinson’s Disease [Seeking Alpha]

VOYAGER THERAPEUTICS (VYGR)  More Company Research Source: Seeking Alpha
Last voyager therapeutics earnings: 5/10 07:04 am Check Earnings Report
US:NASDAQ Investor Relations: ir.voyagertherapeutics.com
PDF FDA accepts Voyager Therapeutics' IND for VY-AADC for advanced Parkinson’s DiseaseVoyager Therapeutics (NASDAQ:VYGR)announces that the FDA has cleared its Investigational New Drug (IND) application forVY-AADC, allowing it to formally initiate clinical trial sites, screen and begin dosing patients for its pivotal Phase 2-3 program for advancedParkinson’s disease.As part of this IND, the chemistry, manufacturing, and controls section included data demonstrating comparability between VY-AADC produced under good manufacturing practice using Voyager’s baculovirus/Sf9 manufacturing process and VY-AADC produced using a mammalian cell system consisting of triple-transfection of human embryonic kidney cells.The Company plans to dose the first patient next quarter.Shares are up6% premarket on light volume.See all stocks on the move »Now read:Voyager Therapeutics: What You Should Know » [Read more]

IMPACT SNAPSHOT EVENT TIME: VYGR
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS